Literature DB >> 9688096

The evolving efforts to control hepatitis B virus.

R Arnot1.   

Abstract

BACKGROUND: Despite the availability of a safe and effective vaccine, hepatitis B virus continues to be a major health threat to populations in both developed and undeveloped countries. In undeveloped countries, this virus often infects children, who then have a high risk of progressing to chronicity. In developed countries, adolescents and adults are at risk of hepatitis B virus transmission during sexual contact. Those who progress to chronic hepatitis B risk premature death and serve as a reservoir for virus transmission.
METHODS: Barriers to global control of hepatitis B virus and strategies for increasing awareness of vaccination for reducing risk for contracting hepatitis B were reviewed.
RESULTS: With the varied patterns of infection and transmission, multiple strategies and recommendations have been proposed by health organizations around the world. The World Health Organization (WHO) has targeted hepatitis B as one of eight infectious diseases that should be controlled through vaccination efforts. Canada and the United States have recently recommended universal hepatitis B vaccination for their adolescent populations.
CONCLUSIONS: This hard-to-reach cohort may benefit from mass media educational efforts, especially the use of television. Control of hepatitis B virus continues to be elusive; therefore, an ongoing commitment to hepatitis B vaccination programs is warranted.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688096     DOI: 10.1097/00006454-199807001-00002

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  2 in total

1.  The economic burden of hepatitis B in Germany.

Authors:  S Harbarth; T Szucs; K Berger; W Jilg
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

2.  The estimation of direct medical costs of treating patients with chronic hepatitis B and C in iran.

Authors:  Hamid Kalantari; Majid Davari; Mojtaba Akbari; Seyed Mehdi Hejazi; Maryam Kalantari; Shahram Zakerin; Zahra Shahshahan
Journal:  Int J Prev Med       Date:  2012-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.